“life-sciences” Archives

in
Entry Author Date Location
Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs 02/13/17 Wisconsin
Allergan to Acquire Fat-Busting Medical Tech Firm Zeltiq for $2.4B 02/13/17 San Francisco
Dear Tom Price: Bundled Payments Help Patients and Reduce Costs 02/11/17 Boston
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
Senate Confirms Price for HHS, But Stock Deals Still Raise Questions 02/10/17 National
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation 02/10/17 National
Xconomy Is Growing: We Need Great Salespeople in SF, Texas, and NY 02/09/17 National
Acorda Touts Success in Parkinson’s Drug Study, Awaits Safety Data 02/09/17 New York
Propeller Health, Novartis to Develop Add-On Sensor for Breezhaler 02/08/17 Wisconsin
Bayer Enlists Trana Discovery to Find New Fungicides for Field Crops 02/08/17 Raleigh Durham
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Kentucky Biotech CEO’s Message For McConnell: I’ll Be Muslim, Too 02/07/17 National
With $294M, Kamen Hopes to Bring Regenerative Medicine “Up to Scale” 02/06/17 Boston
As Iraqi Immigrant, Bio CEO Sees Pros and Cons in U.S. Travel Ban 02/06/17 San Diego
Biomedical Research Has Support, But Questions Linger About Funding 02/03/17 Wisconsin
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
No Details Yet, But Amgen Touts Success in Big Heart Drug Study 02/02/17 San Francisco
Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing 02/02/17 San Diego
Tarveda Nabs $30M More as Versant Helps Fund Cancer Drug Push 02/02/17 Boston
Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof 02/02/17 Boston
Seed-Stage Deals Show Growing Diversity of Agtech Investments 02/01/17 Raleigh Durham
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Still No Official Word From Biopharma Groups About Trump Travel Ban 01/31/17 National
Seres Dissects Failed Microbiome Drug Trial, Suggests Changes to FDA 01/31/17 Boston
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits 01/30/17 San Francisco
Novan Acne Drug Hits Targets in One Late-Stage Trial, Fails Another 01/27/17 Raleigh Durham
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Page 2 of 316 « previous page · next page »